PEOPLE - Changes to the board at Novoste:
This article was originally published in Clinica
Executive Summary
William Hawkins is to join Novoste from American Home Products as president, with effect from June 1. He will replace Thomas Weldon who retains his post as CEO and assumes the additional role of chairman of the US company which specialises in intracoronary radiation therapy.
You may also be interested in...
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.
More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths
Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.